REG - Symphony Environment - Interim Results for 6 Months Ended 30 June 2025
Today 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250930:nRSd2745Ba&default-theme=true
RNS Number : 2745B Symphony Environmental Tech. PLC 30 September 2025
30 September 2025
SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC
("Symphony", the "Company" or the "Group")
Interim Results
Symphony Environmental Technologies Plc (AIM: SYM), the global specialist that
makes plastic products smarter, safer and sustainable, is pleased to announce
its interim financial results for the six-month period ended 30 June 2025
("H1-2025" or the "Period").
Financial highlights
· Group revenue of £2.93 million (H1-2024: £3.44 million)
· Gross margin increased to 51% (H1-2024: 46%)
· Gross profit £1.50 million (H1-2024: £1.57 million)
· Operating loss £0.37 million (H1-2024: £0.42 million)
· Equity subscription raising £2.25 million at 20p per Ordinary
Share
Non-financial highlights
· Study shows d2w significantly reduces and in effect eliminates
microplastics
· Jalisco State in Mexico legislation permits d2w type
oxo-biodegradable technology
· Brazilian, Canadian, Mexican and USA scientific endorsements of
"no microplastics" position paper on d2w
https://www.biodeg.org/subjects-of-interest/microplastics/
· New d2p AI natural insecticide technology trials nearing
completion and showing good efficacy
· NbR (Natural Biodegradable Resin) sales commence with orders in
Canada, the UAE and Saudi Arabia
Since period end
· Irish EPA issues apology over lack of legal authority to approve
or reject d2w in the Irish Market
· Patent application filed for agricultural film incorporating d2w,
NbR and d2p technologies
· Sales growth for d2p Fragrance
· Initial semi-commercial sale of d2p Flame retardant ahead of
final certification - expected in October
· NbR trials underway in Canada, Peru and the UAE
Enquiries:
Symphony Environmental Technologies Plc
Michael Laurier, CEO Tel: +44 (0) 20 8207 5900
Ian Bristow, CFO
www.symphonyenvironmental.com (http://www.symphonyenvironmental.com)
Zeus (Nominated Adviser and Broker)
David Foreman / Emma Burn (Investment Banking) Tel: +44 (0) 203 829 5000
Dominic King (Corporate Broking)
Chairman's statement
The H1-2025 results demonstrate solid progress in our strategic
transformation, with continued implementation of our cost reduction program
leading to further improvements in operating margins. While revenue
performance during the period was affected by order timing in key markets,
this does not reflect the underlying strength of our trading conditions.
We are particularly encouraged by the momentum building across several areas
of the business. As highlighted in our 23 July 2025 update, we have a strong
pipeline of sales opportunities nearing completion, with several expected to
close in the second half of the year or shortly thereafter.
Our core market remains the Middle East, where we have significantly increased
our investment in both time and capital, as outlined in the 8 May 2025 equity
capital raise announcement. Following this, we conducted a comprehensive
market analysis involving a broad cohort of existing and potential customers.
The findings revealed that with targeted structural changes, the business
could upscale materially within a short timeframe. In response, we are
actively upgrading our sales and distribution systems, expanding manufacturing
capacity, and continuing to drive cost efficiencies.
We are very pleased to report new sales in our d2p Fragrance and d2p Flame
retardant technologies, reflecting growing market interest and adoption.
Additionally, trials for our Natural Biodegradable Resin (NbR) are progressing
well in Canada, Peru, and the UAE, reinforcing our confidence in its
commercial potential and environmental impact.
It is disappointing to note that the Environmental Protection Agency (EPA) in
Ireland was recently compelled to issue an apology for a legal error, having
acted outside its authority to approve or disapprove products for sale in the
Irish Republic. We continue to engage in dialogue with the Agency.
This review does not reflect the potential upside from short-term legislative
changes or pending regulatory approvals (including in India), which may
further enhance our performance.
We remain confident in the strength and value of our products, the resilience
of our markets, and the strategic direction of the business.
Equity Fundraising & Valuation
During the Period, the Company raised £2.25 million via an equity
subscription at 20p per share, well above the market price of 3p-demonstrating
strong investor confidence. We welcome Quantum Leap 1.1.1. Fund LP to our
shareholder register, whose investment sets a new benchmark for valuing larger
share blocks. This strategic placement reflects our belief that the AIM market
price undervalues the Company and reinforces our commitment to aligning equity
valuation with long-term potential. Discussions with Quantum regarding further
collaboration are ongoing.
Nicolas Clavel, Chairman
Chief Executive's review
Financial
Revenue for the six months ended 30 June 2025 was £2.93 million (H1-2024:
£3.44 million). The reduction was primarily attributable to the timing of
orders for d2w and d2p masterbatch products.
Gross margins improved during the Period (from 46% in H1-2024 to 51% in
H1-2025) due to further efficiencies in the supply chain. The resultant
contribution after distribution costs increased from 42% to 48% of revenues.
6 months to 6 months to 12 months to
30 June 30 June 31 December
2025 2024 2024
Unaudited Unaudited Audited
£'000 £'000 £'000
2,518 2,781 5,464
d2w masterbatch revenues
d2p masterbatch revenues 238 402 719
Other revenues including finished products 169 254 408
Total revenues 2,925 3,437 6,591
Gross profit 1,500 1,569 3,057
- Gross profit margin 51% 46% 46%
Distribution costs (101) (125) (241)
- Percentage of revenues 4% 4% 4%
Contribution after distribution costs 1,399 1,444 2,816
- Percentage of revenues 48% 42% 43%
Administrative expenses reduced against the same period last year from £1.86
million in H1-2024 to £1.77 million in H1-2025 due to lower staff costs and
professional fees. This reduction was also achieved despite incurring higher
costs related to operations in the Middle East, as mentioned above.
The Group recorded an operating loss of £0.37 million, an improvement from
the £0.42 million loss reported in H1-2024.
The Group's share of the loss from Symphony India's joint venture was
£15,000, compared to £28,000 in 2024.
The Group reports a reduced loss before tax of £0.50 million (H1-2024: £0.54
million) and a reduced loss after tax of £0.50 million (H1-2024: £0.54
million).
The loss per share for the Period was 0.22 pence, an improvement from 0.27
pence in H1-2024.
The Group's working capital position strengthened during the Period with net
cash (excluding convertible loans and lease liabilities) of £0.29 million at
the end of the Period (31 December 2024: net borrowings (excluding convertible
loans and lease liabilities) of £1.02 million). This £1.31 million
improvement was driven by the successful equity raise of £2.25 million at 20p
per share (£2.10 million after costs). On the operational side, net cash used
in operations totalled £0.66 million, up from £0.33 million in H1-2024.
The Group maintains an invoice-discounting facility of £1.75 million to
support funding of outstanding receivables. With the continued improvement in
trading performance and effective utilisation of working capital, the Board is
confident that the Group has sufficient resources to support its operations
and pursue current growth opportunities.
The Group renewed its office lease during the period resulting in additions of
£0.50 million to right of use assets (H1-2024: £nil). The lease is for just
under half of the space leased previously and so will result in large cost-
savings going forward.
d2p ("designed-to-protect") - progress and opportunities
- d2p anti insecticide
A large proportion of d2p revenues is generated from sales of d2p anti-insect
technology ("d2p AI"), the majority being supplied to Rivulis and used in
irrigation pipes sold under their "Defend" trade name. Application for US
Environmental Protection Agency registration continues and we expect to be
able to provide further updates soon. We are also applying for permission to
use within Mexico. Additionally, we are pleased to report that a lengthy
European trial is nearing completion with indications that it will be entering
the commercial phase in the short term.
For food packaging, the d2p AI natural insecticide technology trials continue
and are showing good efficacy.
- d2p and FDA approval for bread packaging and other applications
Marketing of our FDA-approved technology continues in at least eight
territories with ongoing commercial trials, the results of which continue to
show excellent performance by lengthening the life of bread products by
reducing the natural contamination by fungi.
- d2p Flame Retardant ("d2p FR") Development
Two major trials have been underway for more than two years, focused on
refining our flame-retardant formulations and processing techniques to meet
the stringent requirements of international building codes. These trials have
enabled us to progressively enhance product performance and compliance.
We currently have two product developments in progress:
- The first product has reached a key milestone, with its first
small commercial order placed ahead of final certification, which is expected
in October.
- The second product is now entering the final stage of trialling,
with completion anticipated in the coming weeks. Certification will follow and
is expected to take no longer than two months.
In parallel, trials continue for applications in the Middle Eastern
construction market, which, if successful, could unlock significant sales
opportunities in a region with substantial demand.
Additionally, a pipe application using our flame-retardant technology has
entered commercial sales since the period end, with volumes expected to grow
steadily over time.
We are currently working with a major Canadian user of flame-retardants who
is actively exploring a transition to our d2p FR technology. This interest
has been driven in part by ongoing challenges in importing flame retardant
products from the US market, due to the impact of Trump-era tariffs.
Although trials in Canada have been delayed, we expect them to commence
shortly. This collaboration represents a significant opportunity to expand our
footprint in the North American market, particularly with a partner that is
motivated to find a reliable and compliant alternative to their current supply
chain.
- Other d2p technologies
The Group has developed other masterbatch technologies designed to protect and
extend the shelf-life of packaged content. These include corrosion-inhibitors
for sensitive items such as semiconductor chips and metal components; ethylene
and moisture adsorbers for food packaging aimed at reducing food waste; and
antimicrobials for pipes and tanks to help minimise water contamination.
A new d2p scent technology has recently entered commercial use with a
white-goods manufacturer in the Far East. Following an initial modest order,
we are now seeing a steady increase in repeat orders.
We are also expanding the application of our technologies into broader
agricultural markets, particularly in plastic mulch films and other
crop-growing films. While plastic mulch films are widely used to retain soil
moisture and improve crop yields, they pose a serious environmental challenge:
the resulting plastic fragments are extremely difficult, if not impossible, to
collect for recycling after the harvest. Even when collection is feasible, the
fragments are often too contaminated with soil to be recycled effectively. By
incorporating our d2w or NbR biodegradable technologies into these films, we
eliminate this problem. The plastic degrades and organically reintegrates into
the environment, helping to improve soil quality rather than degrade it.
To support this innovation, we have applied for a patent covering the use of
our d2w and NbR biodegradable formulations, as well as our d2p antimicrobial
and insecticide technologies, in mulch films and other crop-growing
applications.
d2w biodegradable technology - progress and opportunities
As recently advised, the Group's core communications strategy focuses on
delivering consistent updates that highlight the benefits of d2w as an
effective, low-cost, non-disruptive, and scientifically validated solution to
the environmental challenges posed by plastic waste-particularly the formation
and persistence of microplastics.
Our scientific position paper on microplastics continues to evolve, greatly
assisted by the Intertek report, showing d2w significantly reduces, and in
effect, eliminates microplastics and is supported by endorsements from several
independent scientists. For further details, please refer
to: https://www.biodeg.org/subjects-of-interest/microplastics/
Saudi Arabia is actively enforcing Phase 1 of their legislation which requires
the use of certified biodegradable technology such as d2w in a range of
plastic products, and we expect the final two phases, (which will cover
virtually all flexible plastic products) to become effective later this
year. Bahrain, Jordan and Yemen also have legislation, making it compulsory
to use plastics with a government approved oxo-biodegradable technology, but
their enforcement remains erratic due mainly to political unrest.
The EPA of Ireland issued an apology to Symphony regarding previous
communications, but it did not change its finding that d2w products had been
scientifically demonstrated to undergo full biodegradation without leaving
persistent microplastics or toxic residues. However, as outlined in our latest
update on this subject, some officials now consider that the EU Commission
Guidelines should be followed, which in their view would bring d2w products
within the scope of the Single-use Plastics Directive (EU) 2019/904. Symphony
maintains, as set out in its recent clarification, that these Guidelines are
not legally binding, were drafted without the benefit of subsequent scientific
evidence, and are in conflict with Recital 15 of the Directive. We therefore
consider that d2w technology remains outside the scope of the Directive.
Other countries in the Middle East and Latin America continue to develop
legislation. As previously advised, Colombia, Costa Rica, Ecuador and Peru now
have legislation that would be favourable if they adopt the correct industry
standard, based on ASTM D 6954.
NbR ("Natural Biodegradable Resin")
As advised, three trial orders have been secured in the Middle East and one in
Canada. Once the trials complete, we anticipate sales momentum to follow,
driven by the compelling value-proposition of our product, priced below the
cost of conventional plastic resin. This pricing advantage, combined with the
opportunity to enhance ESG credentials by reducing the fossil-derived
proportion of the plastic product, at reduced cost, is likely to prove highly
attractive to companies seeking sustainable yet economically viable solutions.
Joint venture in India with Indorama Corporation - Symphony Environmental
India Pvt Ltd ("Symphony India")
The d2w product offered by Symphony India, is covered by the Indian standard
IS 17899 T:2022 "Assessment of Biodegradability of Plastics in varied
conditions." The approval process under this standard continues with the final
part of the mandatory test and certification process targeted to complete
during 2025. Commercial sales are expected to commence after completion of the
process.
Equity Fundraising & Valuation
During the Period, the Company successfully raised £2.25 million through an
equity subscription priced at 20p per share-representing a substantial premium
on the prevailing market price of 3p at the time. We are pleased to welcome
Quantum Leap 1.1.1. Fund LP ("Quantum") to Symphony's shareholder register.
Their investment not only reflects confidence in our technology suite and
potential growth trajectory but also establishes a benchmark that the Board
will use to value larger blocks of shares.
This equity fundraising underscores the Board's belief that the current share
price does not reflect the intrinsic value of the Company.
Our corporate strategy is to maximise the value at which Symphony's equity is
issued to ensure it is consistent with our commercial potential and strategic
direction and ambitions. To that end, we continue discussions with Quantum
regarding potential commercial collaborations.
Outlook
As the world's leading biodegradable plastic technology supplier, we believe
that the adoption of our d2w technology enables both current and prospective
customers to respond more effectively to increasing demands from consumers,
governments, and corporations for stronger ESG policies-particularly in
relation to single-use plastics.
Our d2p range continues to advance as we work through rigorous testing,
trials, and regulatory requirements in collaboration with our global partners.
While the time required for these processes has been considerable, we remain
confident that the opportunities are substantial. Once key trials and
legislative milestones are achieved, we anticipate a significant commercial
impact.
Importantly, the financial results in this review do not reflect the potential
upside from short-term legislative changes and pending regulatory approvals,
which may further enhance our performance.
We remain confident in the strength of our products, the resilience of our
markets, and the strategic direction of the business.
Michael Laurier, Chief Executive
Condensed consolidated interim statement of comprehensive income
6 months to 6 months to 12 months to
30 June 30 June 31 December
2025 2024 2024
Unaudited Unaudited Audited
£'000 £'000 £'000
Revenue 2,925 3,437 6,591
(1,425) (3,534)
Cost of sales (1,868)
Gross profit 1,500 1,569 3,057
Distribution costs (101) (125) (241)
Administrative expenses (1,767) (1,861) (3,903)
Operating loss (368) (417) (1,087)
Finance costs (120) (97) (214)
Share of results of joint ventures (15) (28) (43)
Loss for the Period before tax (503) (542) (1,344)
Taxation - - -
Loss for the Period (503) (542) (1,344)
Total comprehensive income for the Period (503) (1,344)
(542)
Earnings per share:
Basic (0.22)p (0.27)p (0.63)p
Diluted (0.22)p (0.27)p (0.63)p
All results are attributable to the owners of the parent.
There were no discontinuing operations for any of the above periods.
Condensed consolidated interim statement of financial position
At At At
30 June 30 June 31 December
2025 2024 2024
Unaudited Unaudited Audited
£'000 £'000 £'000
ASSETS
Non-current
Property, plant and equipment 100 144 124
Right-of-use assets 513 181 93
Intangible assets 554 648 589
Interest in joint ventures 14 - 29
Investments 130 130 130
1,311 1,103 965
Current
Inventories 599 474 703
Trade and other receivables 2,442 1,980 2,414
Cash and cash equivalents 861 754 718
3,902 3,208 3,835
Total assets 5,213 4,311 4,800
EQUITY AND LIABILITIES
Equity
Equity attributable to owners of
Symphony Environmental Technologies plc
Share capital 2,364 2,251 2,251
Share premium account 7,750 5,767 5,767
Retained earnings (8,919) (7,630) (8,416)
Total equity 1,195 388 (398)
Liabilities
Non-current
Borrowings - 1,500 -
Lease liabilities 370 35 22
370 1,535 22
Current
Borrowings 2,291 546 3,410
Lease liabilities 122 106 25
Trade and other payables 1,235 1,736 1,741
3,648 2,388 5,176
Total liabilities 4,018 3,923 5,198
Total equity and liabilities 5,213 4,311 4,800
Condensed consolidated interim statement of changes in equity
Equity attributable to the owners of Symphony Environmental Technologies plc:
Share Share premium Retained earnings Total
capital equity
£'000 £'000 £'000 £'000
For the six months to 30 June 2025
Balance at 1 January 2025 2,251 5,767 (8,416) (398)
Shares issued 113 1,983 - 2,096
Transactions with owners 113 1,983 - 2,096
Total comprehensive income for the Period - - (503) (503)
Balance at 30 June 2025 2,364 7,750 (8,919) 1,195
Share Share premium Retained earnings Total
capital equity
£'000 £'000 £'000 £'000
For the six months to 30 June 2024
Balance at 1 January 2024 1,848 4,854 (7,102) (400)
Shares issued 403 913 - 1,316
Share-based payments - - 14 14
Transactions with owners 403 913 14 1,330
Total comprehensive income for the Period - - (542) (542)
Balance at 30 June 2024 2,251 5,767 (7,630) 388
Share Share premium Retained earnings Total
capital equity
£'000 £'000 £'000 £'000
For the year to 31 December 2024
Balance at 1 January 2024 1,848 4,854 (7,102) (400)
Issue of share capital 403 913 - 1,316
Share-based payments - - 30 30
Transactions with owners 403 913 30 1,346
Total comprehensive income for the Period - - (1,344) (1,344)
Balance at 31 December 2024 2,251 5,767 (8,416) (398)
Condensed consolidated interim cash flow statement
6 months to 6 months to 12 months to
30 June 30 June 31 December
2025 2024 2024
Unaudited Unaudited Audited
£'000 £'000 £'000
Operating activities:
Loss for the Period after tax (503) (542) (1,344)
Depreciation 97 114 224
Amortisation 35 5 69
Share-based payments - 14 30
Loss on disposal of fixed assets 10 - 2
Foreign exchange (profit)/loss - - 5
Share of loss of joint venture 15 28 43
Interest paid 120 100 214
Change in inventories 104 171 (58)
Change in trade and other receivables (28) (168) (602)
Change in trade and other payables (506) (52) 16
Net cash used in operations (656) (330) (1,401)
Tax received - - -
Net cash used in operating activities (656) (330) (1,401)
Investing activities:
Additions to property, plant and equipment (5) (1) (5)
Additions to right of use assets (29) - -
Additions to intangible assets - - (5)
Equity participation in joint ventures - - (44)
Net cash used in investing activities (34) (1) (54)
Financing activities:
Drawdown cash received from invoice finance facility 2,263 1,972 4,713
Customer receipts repayment of invoice finance facility (2,784) (2,587) (4,395)
Proceeds from share issues 2,096 1,316 1,316
Repayment of lease liability (24) (94) (187)
Lease interest paid (10) (7) (14)
Bank and invoice finance interest paid (58) (93) (95)
Net cash generated/(used) in financing activities 1,483 507 1,338
Net change in cash and cash equivalents 793 176 (117)
Cash and cash equivalents, beginning of Period (90) 32 32
Effect of exchange rate on cash - - (5)
Cash and cash equivalents, end of Period 703 208 (90)
Represented by:
Cash and cash equivalents 861 754 718
Bank overdraft (158) (546) (808)
703 208 (90)
Notes to the interim financial statements
1 Nature of operations and general information
Principal activities of Symphony Environmental Technologies plc (the
"Company") and subsidiaries' (together the "Group") include the development
and supply of environmental plastic masterbatches and other innovative
products.
Symphony Environmental Technologies plc, a public limited company, is the
Group's ultimate parent company. It is incorporated and domiciled in England
(company number 03676824). The address of its registered office is 6 Elstree
Gate, Elstree Way, Borehamwood, Hertfordshire, WD6 1JD, England. The Company's
shares are listed on the AIM market of the London Stock Exchange.
These condensed interim consolidated financial statements ("interim financial
statements" or "interim report") are for the six months ended 30 June 2025.
They do not include all the information required for full annual financial
statements and should be read in conjunction with the consolidated financial
statements of the Group for the year ended 31 December 2024.
The financial information set out in this interim report does not constitute
statutory accounts. The Group's statutory financial statements for the year
ended 31 December 2024 have been filed with the Registrar of Companies. The
auditor's report on those financial statements was unqualified and did not
contain a statement under Section 498(2) or 498(3) of the Companies Act 2006.
These interim condensed consolidated financial statements have not been
audited.
These interim financial statements have been prepared in accordance with the
requirements of International Accounting Standard ("IAS") 34 "Interim
Financial Reporting", and are presented in Pounds Sterling (£), which is the
functional currency of the parent company. They have been prepared under the
historical cost convention. They have also been prepared on the basis of the
recognition and measurement requirements of International Standards as adopted
by the UK, and the policies and measurements are consistent with those stated
in the financial statements for the year ended 31 December 2024.
These interim financial statements were approved by the Board on 29 September
2025.
2 Significant accounting policies
These interim financial statements have been prepared in accordance with the
accounting policies adopted in the last annual financial statements for the
year ended 31 December 2024
3 Seasonal fluctuations
The Group operates in many countries and in many different markets. There are
therefore no formal or considered seasonal fluctuations affecting the
operations of the Group.
4 Segmental analysis
The Board considers that the Group does not have separate operating segments
as defined under IFRS 8.
5 Shares issued
Shares issued are summarised as follows:
6 months to 6 months to Year to
30 June 30 June 31 December 2024
Shares issued and fully paid 2025 2024
- beginning of the Period 225,099,120 184,806,833 184,806,833
- issued during the Period 11,264,875 40,292,287 40,292,287
Total equity shares issued and fully paid at end of the Period
236,363,995 225,099,120 225,099,120
6 Earnings per share and dividends
The calculation of earnings per share is based on the result attributable to
ordinary shareholders divided by the weighted average number of shares in
issue during the Period.
The calculation of diluted earnings per share is based on the basic earnings
per share, adjusted to allow for the issue of shares on the assumed conversion
of dilutive options which were exercisable during the Period.
Reconciliations of the results and weighted average numbers of shares used in
the calculations are set out below:
Basic and diluted 6 months to 6 months to Year to
30 June 30 June 31 December 2024
2025 2024
Loss attributable to owners of the Company £(503,000) £(542,000) £(1,164,000)
Weighted average number of ordinary shares in issue
226,559,106 203,738,715 214,448,178
Basic earnings per share (0.22) pence (0.27) pence (0.63) pence
Dilutive effect of weighted average options - - -
Total of weighted average shares together with dilutive effect of weighted 226,559,106 203,738,715 214,448,178
options - see below
Diluted earnings per share (0.22) pence (0.27) pence (0.63) pence
No dividends were paid for the year ended 31 December 2024.
The Group has been loss-making in all periods presented. The effect of options
for the six months to 30 June 2025 and 30 June 2024, and year to 31 December
2024 are therefore anti-dilutive. Accordingly, the dilutive effect of share
options has not been taken into account of in calculating diluted earnings per
share, since this would decrease the loss per share for each of the periods
reported.
7 Availability of Interim Financial Statements
Paper copies of the Interim Financial Statements will be sent to shareholders
upon request. Shareholders will be able to download a copy of the Interim
Financial Statements from the Group's website. Further copies of the Interim
Financial Statements will be available from the Company's Registered Office at
6 Elstree Gate, Elstree Way, Borehamwood, Hertfordshire WD6 1JD.
NOTES TO EDITORS
About Symphony Environmental
Symphony's d2w masterbatch technology is added to polyethylene (PE) and
polypropylene (PP) products at the manufacturing stage at little or no extra
cost and ensures that if they get into the environment at the end of their
useful life they will not create microplastics and lie or float around for
decades. Instead, they will safely biodegrade, leaving no microplastics or
toxicity. If they get collected during their useful life they can be recycled
with ordinary PE and PP without separation See
https://www.biodeg.org/subjects-of-interest/recycling-2/
(https://www.biodeg.org/subjects-of-interest/recycling-2/)
Symphony also supplies a range of plastic technologies under its d2p (designed
to protect) brand www.d2p.net (http://www.d2p.net) to provide protection
against insects, viruses, bacteria, fungi, rodents, odours, and fire. It has
also introduced a new product under its NbR brand
https://www.symphonyenvironmental.com/natural-biodegradable-resin/
(https://www.symphonyenvironmental.com/natural-biodegradable-resin/) to reduce
the amount of fossil-derived material in plastic products.
Symphony has a diverse and growing customer-base and has established itself as
an international business with over 70 distributors around the world. Products
made with Symphony's plastic technologies are now available in nearly 100
countries and in many different product applications. Symphony itself is
certified according to ISO9001 and ISO14001.
Symphony participates in the Committee work of the British Standards Institute
(BSI), the American Standards Organisation (ASTM), the European Standards
Organisation (CEN), and the International Standards Organisation (ISO).
Further information on the Group can be found at
www.symphonyenvironmental.com and twitter @SymphonyEnv
See also Symphony on Instagram and Linkedin.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IR PPUCCBUPAGABRecent news on Symphony Environmental Technologies
See all newsREG - Symphony Environment - Interim Results for 6 Months Ended 30 June 2025
AnnouncementRCS - Symphony Environment - CEO Speaks at US SPE Conference
AnnouncementREG - Symphony Environment - EPA Ireland update
AnnouncementREG - Symphony Environment - Result of AGM
AnnouncementREG - Symphony Environment - AGM Statement
Announcement